Screening In-Depth Focus 2018

Posted: 1 June 2018 | | No comments yet

This In-Depth Focus reviews the history of cancer treatments, looks at improving the translation of disease biology though phenomics, and considers how to enhance cell bioprocessing through cell-based combinatorial culture.

Screening In-Depth Focus #2 2018
  • Cancer drug screening: the historical perspective
    Chemotherapy with cytotoxic and growth inhibitory drugs have played an important role in cancer therapy, used either alone or in combination with other treatment modalities such as surgery, radiation or biological therapy. Chemotherapy, in most instances, was the only alternative treatment for metastatic cancer – mainly given as drug combinations.
  • Improving the translation of disease biology though phenomics
    Today any self-respecting pharma-focused conference agenda isn’t complete without at least one session on the use of more physiological phenotypic assays for drug discovery, writes Paul Andrews.
  • Regenerative medicine: enhance cell bioprocessing through cell-based combinatorial culture
    Regenerative medicine has emerged as one of the major areas of modern medical therapy. Its primary objective is to restore or establish normal function through the regeneration or replacement of diseased cells, tissues or entire organs. There are a variety of methods and approaches by which this can be achieved. These techniques include cell and gene therapy, tissue engineering or regenerative drug therapy.

This In-Depth Focus is restricted - login or subscribe free to access

Screening the future innovations in drug discoveryThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here